Sandbox Reserved 1706

spinqualitylabelsall models Structural representation of the GAP protein Neurofibromin in its open conformation. The N-C HEAT ARM of both monomers are in black. The GRD domain is in Cyan. The GAPex domain is in Magenta. The Sec14-PH domain is in Yellow. PDB code:7PGT Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image

Contents 1 Introduction 2 Function 3 Structure 3.1 Domains 3.1.1 N-C HEAT/ARM 3.1.2 GRD 3.1.3 GAPex 3.1.4 Sec14-PH 3.2 Conformations 3.2.1 Closed conformation 3.2.1.1 Zinc Stabilized 3.2.2 Open conformation 3.2.3 Conformational Change Linkers 4 Ras Binding 5 SPRED 1 6 Clinical Relevance 7 References

Introduction

Neurofibromatosis Type 1 is a genetic disorder caused by mutations in the tumor suppressor gene NF1 that codes for the GTPase-activating protein neurofibromin.^[1] Neurofibromin is closely involved in signaling pathways such as MAPK/ERK, P13K/AKT/mTOR, and other cell signaling pathways that use Ras ^[1]. Decreased activity of neurofibromin due to mutation can lead to tumor growth along nerves. As it is ubiquitous expression, NF1 misregulation can cause systemic tumor growth. Neurofibromin is localized to the cytosol but is recruited to the plasma membrane to inactivate Ras. The structure of neurofibromin was determined by high-resolution single particle cryo-EM. These structures illustrated the domain architecture and conformational changes in neurofibromin, controlling Ras binding and inactivation. ^[1][2][3][4]

Function

Neurofibromin is a GTPase-activating protein that binds to Ras, a GTPase, to increase its inherent hydrolysis of GTP to GDP (Figure 1). This inactivates the cell signaling of Ras until reactivated by GTP exchange. Neurofibromin has two structural conformations, the open and closed conformation. Neurofibromin only binds to Ras in its open conformation. ^[2][3][4]

Structure

Neurofibromin is a protein dimer that exists in and conformations. The exact initiation of structural rearrangement is currently unknown and a point of further research. ^[2][3]. Both protomers contain 5 separate domains, a N-HEAT/ARM, C-HEAT/ARM, GRD binding site, GAPex domain, and Sec14-PH domain.

Domains

N-C HEAT/ARM

The N-C HEAT/ARM are two separate but similar connected domains that make up the backbone of the protomer; (N-Terminal) and (C-Terminal). HEAT and ARM are acronyms for a trope of repeating helical structures. Structurally, the N-HEAT/ARM consists of various helices and loops that interconnect on one of the existing protomers. The N-HEAT/ARM is critical in stabilization and linking the catalytic and core domains. The N-HEAT/ARM in its linkage with the GRD catalytic domain also has a direct impact on the relative conformational change from the active (Ras BOUND) to inactive (Ras unbound) states. The Zn2+ binding site also extends from the N-HEAT ARM just before the GRD and SEC14-PH domains. The C-HEAT/ARM plays similar roles to the N-HEAT/ARM by stabilizing and linking the GRD and SEC14-PH domain and contributing to the conformational changes from the closed to open state.^[3][4]

GRD

Neurofibromin’s main catalytic domain is the binding site. Linked structurally to both HEAT/ARMs, it consists of mainly loops and helices. There is one single GRD binding site per protomer. In the closed state, Ras cannot bind the GRD site due to a steric hindrance in which Ras clashes with the N-HEAT/ARM. Within the GRD site, the critical binding site residue is Arg1276. GRD also can bind to SPRED-1 to be recruited from the cytosol to the plasma membrane. ^[3][4]

GAPex

The of the GRD site lies between the Sec14-PH and GRD catalytic sites. This domain is non-catalytic and structurally consists of various loops and helices. Its may contribute to the binding of SPRED-1 to the GRD site. ^[3][4]

Sec14-PH

The is linked and extends out from the HEAT/ARM’s. Sec14-PH functions as a membrane associated domain and using a hydrophobic cavity binds to neurofibromin the plasma membrane. The closed conformation also blocks Sec14-PH binding to the cell membrane due to blocking by GRD. ^[3][4]

Conformations

Closed conformation

Ras is unable to bind to the GRD binding site when both of the neurofibromin protomers are in the . In the closed conformation, one protomer has its domains shifted by a 130° rotation of three separate conformational change linkers. That rotation places Arg1276 in an orientation where binding of Y32 of Ras is sterically hindered by E31. ( ) Ras binding to the GRD site is inhibited by steric occlusion from the N-HEAT/ARM. The closed conformation can exist naturally without any form of stabilization but exists in a natural equilibrium with the open conformation.^{[2] [3][4]}

Zinc Stabilized

The closed conformation is stabilized by a zinc ion that prevents the shift back to the open conformation. Zinc binding is chelated by three residues (). These three residues are contributed by the N-HEAT domain (Cys1032) and the GAPex-subdomain (His1558 and His1576). Zinc stabilization keeps Neurofibromin in the closed conformation, inhibiting Ras binding.^[2][3][4]

Open conformation

In the , one protomer is shifted to allow Ras binding, while the other protomer remains in the closed conformation. In the open conformation one protomer is rotated 90°, facilitating binding between Y32 of RAS and Arg1276. ( ) in the GRD site. To allow Ras binding, the GRD and Sec14-PH domains are reoriented away from one another and the GRD site is accessible for Ras binding. This conformational change to the open conformation is driven by rearrangement of three separate linkers (L1, L2, L3).^{[2] [3][4]}

Conformational Change Linkers

These three helical linkers (L1, L2, and L3) undergo rotations to relocate the GRD and Sec14-PH sites ( and ). Linker 1 (L1) consists of a loop connected by two helices from L1173-M1215 and is the main contributor in rotation of the GRD domain. The rotation of L1 to the open conformation causes N-HEAT/ARM α helix 48 and GRD helix 49 to extend out, aligning to form a hinge point at G1190. The GRD relocation is assisted by Sec14-PH relocation, which is initiated by Linker 3(L3) from Q1835 to G1852. Movement of L3 is further supported by rearrangement of the proline rich section of the C-HEAT/ARM. L1 and L3 also move closer to each other in the open conformation initiating rearrangement of the GRD and Sec14-PH domain. Linker 2 (L2) consists of residues G1547-T1565 and begins at helix 63, the final helix of the GRD site, and connects into the short loop of α helix 65 of the Sec14-PH domain and also assists in shifting the Sec14-PH away from the GRD site. The combination of these three linkers are largely responsible for the conformational shift of the closed and open conformation.^[3][4]

Ras Binding

Arg1276 is the critical residue within the GRD site for Ras activation. When , the arginine finger binds to the backbone γ-carbon of Y32 in Ras to assist in eventual hydrolysis of GTP. When the interaction between Y32 and GRD (R1276) is blocked by E31. Removal of the inhibition of E31 from Ras by R1276 from Neurofibromin allows for the normal function of neurofibromin in the rapid rate increase of GTP hydrolysis upon Ras binding. Mutations to the arginine finger slow GTPase activating reaction of neurofibromin.^[2][3][4]

SPRED 1

is another peripheral protein that interacts with the GRD domain of Neurofibromin. SPRED 1 recruits Neurofibromin from the cytosol to the plasma membrane to interact with Ras. Binding of SPRED 1 can occur in either the open or closed conformation and causes a structural rearrangement of the GRD and GAPex domains that has yet to be structuralized.^[3][4]

Clinical Relevance

Germline mutations are common in NF1 and often cause genetic tumor syndrome through misregulation of the Ras signaling pathway. ^[5] Somatic mutations among NF1 are also extremely common. In germline mutations and some somatic mutations of NF1, tumors develop along the deep epidermis layer of the skin. Understanding how mutations affect the structure and function of neurofibromin will allow for advancements in treatment. ^[1][5][6]

References

1. ↑ ^{1.0 1.1 1.2 1.3} Bergoug M, Doudeau M, Godin F, Mosrin C, Vallee B, Benedetti H. Neurofibromin Structure, Functions and Regulation. Cells. 2020 Oct 27;9(11). pii: cells9112365. doi: 10.3390/cells9112365. PMID:33121128 doi:http://dx.doi.org/10.3390/cells9112365
2. ↑ ^{2.0 2.1 2.2 2.3 2.4 2.5 2.6} Bourne HR. G proteins. The arginine finger strikes again. Nature. 1997 Oct 16;389(6652):673-4. doi: 10.1038/39470. PMID:9338774 doi:http://dx.doi.org/10.1038/39470
3. ↑ ^{3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10 3.11 3.12} Lupton CJ, Bayly-Jones C, D'Andrea L, Huang C, Schittenhelm RB, Venugopal H, Whisstock JC, Halls ML, Ellisdon AM. The cryo-EM structure of the human neurofibromin dimer reveals the molecular basis for neurofibromatosis type 1. Nat Struct Mol Biol. 2021 Dec;28(12):982-988. doi: 10.1038/s41594-021-00687-2., Epub 2021 Dec 9. PMID:34887559 doi:http://dx.doi.org/10.1038/s41594-021-00687-2
4. ↑ ^{4.00 4.01 4.02 4.03 4.04 4.05 4.06 4.07 4.08 4.09 4.10 4.11} Naschberger A, Baradaran R, Rupp B, Carroni M. The structure of neurofibromin isoform 2 reveals different functional states. Nature. 2021 Nov;599(7884):315-319. doi: 10.1038/s41586-021-04024-x. Epub 2021, Oct 27. PMID:34707296 doi:http://dx.doi.org/10.1038/s41586-021-04024-x
5. ↑ ^{5.0 5.1} Kiuru M, Busam KJ. The NF1 gene in tumor syndromes and melanoma. Lab Invest. 2017 Feb;97(2):146-157. doi: 10.1038/labinvest.2016.142. Epub 2017, Jan 9. PMID:28067895 doi:http://dx.doi.org/10.1038/labinvest.2016.142
6. ↑ Sabatini C, Milani D, Menni F, Tadini G, Esposito S. Treatment of neurofibromatosis type 1. Curr Treat Options Neurol. 2015 Jun;17(6):355. doi: 10.1007/s11940-015-0355-4. PMID:25917340 doi:http://dx.doi.org/10.1007/s11940-015-0355-4